Prime Medicine, Inc. Common Stock (PRME) earnings · rev $4.6M
These earnings events as JSON? API free 100/dayPrime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
This PRME earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
When the next PRME 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 55.3% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full PRME research stays on the stock page; the tape stays on the quote page.
PRME earnings FAQ
What are PRME's latest revenue and net income?
Latest cached Prime Medicine, Inc. Common Stock (PRME) revenue for Dec 31, 2025 was $4.6M. Net income was -$201.1M. Statements: https://lician.com/financials/prme
What is PRME's latest diluted EPS?
Latest cached Prime Medicine, Inc. Common Stock (PRME) diluted EPS for Dec 31, 2025 was -$1.35.
What period does the latest PRME earnings print cover?
The latest cached Prime Medicine, Inc. Common Stock (PRME) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did PRME revenue change from the prior cached period?
Cached Prime Medicine, Inc. Common Stock (PRME) revenue was up 55.3% from $3.0M (Dec 31, 2024) to $4.6M (Dec 31, 2025). Statements: https://lician.com/financials/prme
Where are PRME earnings listed?
Cached earnings facts for Prime Medicine, Inc. Common Stock (PRME) are listed at https://lician.com/earnings/prme. Statements: https://lician.com/financials/prme
Not investment advice.